Ceribell (CBLL) Income towards Parent Company (2023 - 2026)
Ceribell (CBLL) posted Income towards Parent Company of -$19.7 million for Q1 2026, down 45.91% on a QoQ basis from -$13.5 million in Q4 2025, and down 54.47% year-over-year from -$43.4 million in Q1 2025.
Ceribell (CBLL) Income towards Parent Company (2023 - 2026) Analysis & Trends
Ceribell's Income towards Parent Company history runs 4 years deep, the most recent figure standing at -$19.7 million for Q1 2026.
- Quarterly Income towards Parent Company fell 54.47% year-over-year to -$19.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$60.4 million (down 35.03% YoY) and the FY2025 annual result came in at -$54.0 million, down 69.15% from the prior year.
- Income towards Parent Company was -$19.7 million for Q1 2026 at Ceribell, down from -$13.5 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at -$7.1 million in Q3 2023 and bottomed at -$19.7 million in Q1 2026.
- A 4-year average of -$11.7 million and a median of -$12.6 million in 2024 frame the typical range for Income towards Parent Company.
- Annual changes were most pronounced in 2025 — Income towards Parent Company fell 7.56% — and 2026, when it slumped 54.47%.
- Ceribell's Income towards Parent Company stood at -$8.3 million in 2023, then tumbled by 51.99% to -$12.6 million in 2024, then dropped by 7.56% to -$13.5 million in 2025, then plunged by 45.91% to -$19.7 million in 2026.
- Business Quant data shows CBLL's Income towards Parent Company at -$19.7 million in Q1 2026, -$13.5 million in Q4 2025, and -$13.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Ceribell | 677.56 Mn | 536.38 Mn | 23.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.74 Mn |
| Dec 31, 2025 | -13.53 Mn |
| Sep 30, 2025 | -13.47 Mn |
| Jun 30, 2025 | -13.64 Mn |
| Mar 31, 2025 | -12.78 Mn |
| Dec 31, 2024 | -12.58 Mn |
| Sep 30, 2024 | -10.42 Mn |
| Jun 30, 2024 | -8.94 Mn |
| Mar 31, 2024 | -8.52 Mn |
| Dec 31, 2023 | -8.27 Mn |
| Sep 30, 2023 | -7.05 Mn |